Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damien Sene

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Autoimmunity Reviews|April 14, 2015
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndromeNicolas Noel, Fabien Dutasta, Nathalie Costedoat-Chalumeau, et al.
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis NetworkHélène Vallet, Pascal Seve, Lucie Biard, et al.
Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.
Journal of Clinical Immunology|May 20, 2023
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 PneumoniaQuentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.
European Journal of Haematology|July 21, 2021
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective studyJoris Galland, Benjamin Thoreau, Maxime Delrue, et al.
Viruses|April 30, 2021
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 PatientsBenjamin Thoreau, Joris Galland, Maxime Delrue, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Autoimmunity Reviews|April 14, 2015
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndromeNicolas Noel, Fabien Dutasta, Nathalie Costedoat-Chalumeau, et al.
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis NetworkHélène Vallet, Pascal Seve, Lucie Biard, et al.
Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.
Journal of Clinical Immunology|May 20, 2023
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 PneumoniaQuentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.
European Journal of Haematology|July 21, 2021
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective studyJoris Galland, Benjamin Thoreau, Maxime Delrue, et al.
Viruses|April 30, 2021
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 PatientsBenjamin Thoreau, Joris Galland, Maxime Delrue, et al.
Pageof 6